RECONSTITUTION OF SCID MICE WITH HUMAN LYMPHOID AND MYELOID CELLS AFTER TRANSPLANTATION WITH HUMAN FETAL BONE-MARROW WITHOUT THE REQUIREMENT FOR EXOGENOUS HUMAN CYTOKINES
Tr. Kollmann et al., RECONSTITUTION OF SCID MICE WITH HUMAN LYMPHOID AND MYELOID CELLS AFTER TRANSPLANTATION WITH HUMAN FETAL BONE-MARROW WITHOUT THE REQUIREMENT FOR EXOGENOUS HUMAN CYTOKINES, Proceedings of the National Academy of Sciences of the United Statesof America, 91(17), 1994, pp. 8032-8036
Investigation of human hematopoietic maturation has been hampered by t
he lack of in vivo models. Although engraftment of irradiated C.B-17 s
cid/scid (SCID) mice with human progenitor cells occurred after infusi
on with human pediatric bone marrow cells, significant engraftment of
the mouse bone marrow with human cells was dependent upon continuous t
reatment with exogenous human cytokines. Furthermore, despite cytokine
treatment, only minimal peripheral engraftment of these mice with hum
an cells was observed. In the present study, after infusion of irradia
ted SCID mice with pre cultured human fetal bone marrow cells (BM-SCID
-hu mice), their bone marrow became significantly engrafted with human
precursor cells and their peripheral lymphoid compartment became popu
lated with human B cells and monocytes independently of the administra
tion of extraneous human cytokines. Examination of the bone marrow of
the BM-SCID-hu mice for human cytokine mRNA gene expression demonstrat
ed human leukemia inhibitory factor mRNA and interleukin 7 mRNA in nin
e of nine BM-SCID-hu mice and macrophage-colony-stimulating factor mRN
A in seven of eight BM-SCID-hu mice. This was an intriguing observatio
n because these cytokines regulate different stages of human hematopoi
esis. Since engraftment occurs in the absence of exogenous cytokine tr
eatment, the BM-SCID-hu mouse model described should provide a useful
in vivo system for studying factors important in the maturation of hum
an myeloid and lymphoid cells in the bone marrow and the behavior of t
he mature human cells after dissemination into the peripheral lymphoid
tissue.